In contrast to DLBCL/HGBL-MYC/BCL2, aggressive lymphomas with either large cell or high-grade morphology and an MYC/BCL6 double hit, but lacking BCL2 translocations, form a heterogeneous tumor category without indications of a unifying biology. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.